Growth Metrics

Chemours (CC) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to -$6.0 million.

  • Chemours' Gains from Investment Securities fell 25000.0% to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.0 million, marking a year-over-year increase of 1692.31%. This contributed to the annual value of $98.0 million for FY2024, which is 8148.15% up from last year.
  • According to the latest figures from Q3 2025, Chemours' Gains from Investment Securities is -$6.0 million, which was down 25000.0% from -$16.0 million recorded in Q2 2025.
  • In the past 5 years, Chemours' Gains from Investment Securities registered a high of $146.0 million during Q4 2024, and its lowest value of -$48.0 million during Q1 2025.
  • Over the past 5 years, Chemours' median Gains from Investment Securities value was $9.0 million (recorded in 2021), while the average stood at $19.1 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 15000.0% in 2021, then plummeted by 32222.22% in 2023.
  • Chemours' Gains from Investment Securities (Quarter) stood at $118.0 million in 2021, then decreased by 19.49% to $95.0 million in 2022, then increased by 18.95% to $113.0 million in 2023, then grew by 29.2% to $146.0 million in 2024, then crashed by 104.11% to -$6.0 million in 2025.
  • Its Gains from Investment Securities stands at -$6.0 million for Q3 2025, versus -$16.0 million for Q2 2025 and -$48.0 million for Q1 2025.